AstraZeneca COVID-19 vaccine study paused after one illness

by on

Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a patient suffered a serious side effect or if the illness had nothing to do with the shot.

Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a patient suffered a serious side effect or if the illness had nothing to do with the shot.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: